SOUTH v. FEDERAL BUREAU OF PRISONS

CourtDistrict Court, D. New Jersey
DecidedOctober 13, 2021
Docket1:20-cv-09045
StatusUnknown

This text of SOUTH v. FEDERAL BUREAU OF PRISONS (SOUTH v. FEDERAL BUREAU OF PRISONS) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SOUTH v. FEDERAL BUREAU OF PRISONS, (D.N.J. 2021).

Opinion

[Doc. No. 17, 22] UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY CAMDEN VICINAGE

MS. JASON SOUTH,

Plaintiff,

v. Civil No. 20-09045 (RBK)(MJS)

FEDERAL BUREAU OF PRISONS,

Defendants.

O P I N I O N & O R D E R Plaintiff Jason South (“plaintiff”), a transgender inmate presently confined at FCI Sheridan, a correctional institution with the Federal Bureau of Prisons (“BOP”), filed a hand-written pro se complaint and motion for a preliminary injunction on July 17, 2020 alleging civil rights violations against the BOP and seeking transfer to a female facility. Upon screening plaintiff’s complaint under 28 U.S.C. § 1915, Judge Kugler issued an Order on August 6, 2020 dismissing with prejudice plaintiff’s Bivens claims against the BOP but permitting claims brought under the Rehabilitation Act and Affordable Care Act to proceed. Doc. Nos. 4, 5; South v. Fed. Bureau of Prisons, No. CV209045, 2020 WL 4530050 (D.N.J. Aug. 6, 2020). The Order further directed the appointment of pro bono counsel and the filing of an amended complaint within (20) days of appointment. Doc. No. 5. On August 11, 2020, plaintiff filed a motion to amend the complaint. Doc. No. 6. On October 5, 2020, plaintiff filed a motion to transfer this case to the Eastern District of Michigan. Doc. No. 10. Pro

bono counsel was then appointed on October 28, 2020. Doc. No. 11. Shortly thereafter, on November 2, 2020, the Court issued an Order [Doc. No. 14] denying plaintiff’s motion to amend [Doc. No. 6] to permit counsel to evaluate the case and determine if amendment was appropriate. Plaintiff subsequently filed a motion to withdraw the motion to transfer on November 10, 2020 [Doc. No. 15], which the Court granted on January 20, 2021 [Doc. No. 16]. On March 9, 2021, plaintiff brought the present motion seeking leave to amend the complaint to name Carl Sceusa1 (“defendant Sceusa”) and allege a novel claim against him, remove certain claims against BOP, and add factual averments. Specifically, the Proposed Amended Complaint asserts claims against defendant Sceusa

for cruel and unusual punishment under the Eighth Amendment and discrimination under the Affordable Care Act (“ACA”), as well as a claim against BOP for violation of the Rehabilitation Act of 1973 (“RA”).2 Doc. No. 17 (the “Motion”). The Motion is unopposed.

1 Plaintiff proposes to allege that Carl Sceusa is a medical doctor employed by or at FCI Fort Dix.

2 Plaintiff’s Proposed Amended Complaint makes two references to 42 U.S.C. § 1983. See Proposed Amended Compl. ¶¶ 1, 5. There being no causes of action expressly asserted under § 1983 in Counts One, Two, or Three, no state actors named, and no mention of § 1983 in The Court exercises its discretion to decide plaintiff’s Motion without oral argument. See FED. R. CIV. P. 78; L. CIV. R. 78.1. For the reasons to be discussed, plaintiff’s Motion is GRANTED.

Factual Background The Court draws the following facts from plaintiff’s proposed amended complaint and takes them as true for the purposes of the Motion. Plaintiff is a transgender inmate, male to female, who has been in federal custody for fifteen years and housed in ten male correctional facilities. Proposed Amended Compl. ¶ 11. Plaintiff suffers from numerous afflictions, including but not limited to borderline personality disorder, bipolar disorder, panic disorder,

depression, anxiety, and post-traumatic stress disorder and has a history of self-injury, suicidal ideation, and suicide attempt. Id. at ¶ 12. In May 2019, while housed at FCI Danbury in Danbury, Connecticut, BOP Psychology Services diagnosed plaintiff with gender dysphoria. Id. at ¶ 14. For inmates diagnosed with gender dysphoria, BOP prescribes gender-affirming hormone therapy. Id. at ¶ 15. In or around November 2019, plaintiff was prescribed and began consuming 6 milligrams (“mg”) of Estradiol, an estrogen hormone treatment. Id. at ¶ 20. Plaintiff alleges that in or around December 2019, plaintiff was transferred from FCI Danbury to FCI Fort Dix following a sexual and physical assault against plaintiff

counsel’s briefing, the Court does not construe these references as plaintiff’s intent to pursue a claim under that statute. by inmates at FCI Danbury. Id. at ¶ 21. While confined at Fort Dix, plaintiff continued receiving 6 mg of Estradiol. Id. at ¶ 23. Plaintiff alleges that in or around March 2020, plaintiff was

sexually harassed by two inmates at Fort Dix. Id. at ¶ 24. Plaintiff then requested transfer to a female facility. Id. On April 23, 2020, defendant Sceusa discontinued plaintiff’s standing order for 6 mg daily of Estradiol and submitted a new medical order reducing plaintiff’s Estradiol treatment from 6 mg to 2 mg daily. Id. at ¶ 25. On May 18, 2020, plaintiff received a Suicide Risk Assessment after being removed from her unit following a disagreement with another inmate. Id. at ¶ 26. While being

assessed by Psychology Services for potential suicidal ideation, plaintiff was informed that incident reports would be filed against her and that she was being transferred to the Special Housing Unit. Id. This allegedly exacerbated plaintiff’s distress, and she responded by attempting to stab herself in the leg with a mechanical pencil. Id. Plaintiff was then placed on suicide watch immediately thereafter at which time she threatened to hang herself, expressed a desire to have her male genitals cut off, banged her head on the wall causing it to bleed, tied a blanket around her neck and cut her wrist using a damaged mesh wall in the suicide watch cell. Id. at ¶ 27. Plaintiff then informally complained to Psychology services that she believed her missed

hormone treatments contributed to her negative behavior. Id. at ¶ 28. The next day, on May 19, 2020, defendant Sceusa increased plaintiff’s Estradiol prescription from 2 mg back to 6 mg. Id. at ¶ 29. Plaintiff attempted suicide again on May 20, 2020. Id. at ¶

30. On May 22, 2020, BOP’s National Inmate Appeals Administrator issued an Administrative Remedy Response (“Response”) addressing plaintiff’s sexual harassment complaint and concern with defendant Sceusa having decreased the dose of Estradiol. Id. at ¶ 31. The Response notified plaintiff that the Transgender Executive Council denied the request for transfer to a female facility because plaintiff’s placement in a male facility was appropriate based on

factors set forth in the BOP’s Transgender Offender Manual. Id. In addition, the Response stated that plaintiff’s most recent laboratory results indicated her hormone levels had not been maximized or stabilized. Id. As such, the Response stated the medications were adjusted and hormone levels would continue to be monitored by Health Services staff at the institution. Id. Plaintiff was seen again by defendant Sceusa on June 8, 2020 and alleges that in addition to referring to plaintiff in the male pronoun against her wishes, defendant Sceusa denied plaintiff’s request for a prophylactic medication to prevent sexually transmitted disease. Id. at ¶ 33. In sum, plaintiff proposes to allege that the BOP and defendant Sceusa’s intentional actions caused plaintiff severe physical, mental, and emotional anguish resulting in self-harm,

delayed plaintiff’s male to female transition, and negatively impacted plaintiff’s ability to transfer to a female correctional facility. Id. at ¶ 1. Discussion

Motions to amend are governed by FED. R. CIV. P. 15. See Mullin v. Balicki, 875 F.3d 140, 149 (3d Cir. 2017).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Davis v. Passman
442 U.S. 228 (Supreme Court, 1979)
Carlson v. Green
446 U.S. 14 (Supreme Court, 1980)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Warren General Hospital v. Amgen Inc.
643 F.3d 77 (Third Circuit, 2011)
Travelers Indem. Co. v. Dammann & Co., Inc.
594 F.3d 238 (Third Circuit, 2010)
Ahmed v. Dragovich
297 F.3d 201 (Third Circuit, 2002)
Coley v. Iwaugwu
303 F. App'x 109 (Third Circuit, 2008)
Lewal v. Ali
289 F. App'x 515 (Third Circuit, 2008)
Ziglar v. Abbasi
582 U.S. 120 (Supreme Court, 2017)
Joan Mullin v. Karen Balicki
875 F.3d 140 (Third Circuit, 2017)
Peter Bistrian v. Troy Levi
912 F.3d 79 (Third Circuit, 2018)
Harrison Beverage Co. v. Dribeck Importers, Inc.
133 F.R.D. 463 (D. New Jersey, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
SOUTH v. FEDERAL BUREAU OF PRISONS, Counsel Stack Legal Research, https://law.counselstack.com/opinion/south-v-federal-bureau-of-prisons-njd-2021.